Gene symbol | Description | Forward primer | Reverse primer | Product length (bp) |
---|---|---|---|---|
TTR | Transthyretin | CTACTGGAAGGCACTTGGCA | AGGGCTGTGGTGGAGTAAGA | 132 |
APOC3 | Apolipoprotein C-III | AGGACACCTCCCTTCTGGAC | GTCGGTGAACTTGCCCTTGA | 179 |
RBP4 | Retinol-binding protein 4 | CGGACTATGACACCTACGCC | GTGACACCCTCCATGTTGCT | 245 |
ADAM19 | ADAM metallopeptidase domain 19 | AGTTTACGAACCAGACCAAGAA | GCATAATCAGCCACAAGGTAAAG | 97 |
FADS1 | Fatty acid desaturase 1 | CGTGATTGACCGGAAGGTGT | TAGTCGGTTCAAAGCTGGGC | 203 |
FADS2 | Fatty acid desaturase 2 | GCGCAGATGCCTACCTTT | TAAATCAAGGTCGCGGTGGAA | 198 |
ADORA1 | Adenosine A1 receptor | CCTCTTCCTCTTTGCCCTTAC | GTAGATGAGGATGCTGGACTTG | 97 |
CASQ1 | Calsequestrin 1 | CCAACAGCGAAGAGGAGATT | TCCTCCCAGGTCTCATACATAC | 97 |
MAPK1 | Mitogen-activated protein kinase 1 | CCCTCACAAGAGGATTGAAGTAG | GGCTCATCACTTGGGTCATAA | 78 |
FADD | Fas (TNFRSF6)-associated via death domain | GGGCGGGAAGTGTTTGATT | CTCCCTGGCCAATTCTGTTATG | 83 |
CCL4 | C-C motif chemokine ligand 4 | GCAAGACCATGAAGCTCTGC | AAGCTTCCGCACGGTGTATG | 137 |
TOP2B | Topoisomerase (DNA) II beta | AACTGGATGATGCTAATGATGCT | TGGAAAAACTCCGTATCTGTCTC | 464 |